Last reviewed · How we verify

i.v fentanyl, AeroLEF

YM BioSciences · Phase 1 active Small molecule

i.v fentanyl, AeroLEF is a Small molecule drug developed by YM BioSciences. It is currently in Phase 1 development. Also known as: fentanyl, AeroLEF.

At a glance

Generic namei.v fentanyl, AeroLEF
Also known asfentanyl, AeroLEF
SponsorYM BioSciences
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about i.v fentanyl, AeroLEF

What is i.v fentanyl, AeroLEF?

i.v fentanyl, AeroLEF is a Small molecule drug developed by YM BioSciences.

Who makes i.v fentanyl, AeroLEF?

i.v fentanyl, AeroLEF is developed by YM BioSciences (see full YM BioSciences pipeline at /company/ym-biosciences).

Is i.v fentanyl, AeroLEF also known as anything else?

i.v fentanyl, AeroLEF is also known as fentanyl, AeroLEF.

What development phase is i.v fentanyl, AeroLEF in?

i.v fentanyl, AeroLEF is in Phase 1.

Related